During the past decade, Medical Oncology and Hematology Associates-West Des Moines conducted 175 clinical trials. In the 10-year time frame, 175 clinical trials started and 172 clinical trials were completed, i.e. on average, 98.3% percent of trials that started reached the finish line to date. In the past 5 years, 77 clinical trials started and 80 clinical trials were completed. i.e. 103.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Oncology and Hematology Associates-West Des Moines" #1 sponsor was "National Cancer Institute (NCI)" with 166 trials, followed by "Alliance for Clinical Trials in Oncology" with 67 trials sponsored, "SWOG Cancer Research Network" with 47 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 26 trials sponsored and "Gynecologic Oncology Group" with 26 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Oncology and Hematology Associates-West Des Moines" #1 collaborator was "National Cancer Institute (NCI)" with 182 trials as a collaborator, "NRG Oncology" with 43 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 9 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Medical Oncology and Hematology Associates-West Des Moines" are "Breast Cancer" (19 trials), "Recurrent Ovarian Carcinoma" (14 trials), "Stage IV Lung Cancer AJCC v8" (12 trials), "Lung Cancer" (11 trials) and "Recurrent Breast Carcinoma" (11 trials). Many other conditions were trialed in "Medical Oncology and Hematology Associates-West Des Moines" in a lesser frequency.

Most popular intervention types in "Medical Oncology and Hematology Associates-West Des Moines" are "Drug" (278 trials), "Other" (207 trials), "Biological" (146 trials), "Procedure" (81 trials) and "Radiation" (60 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (97 trials), "Quality-of-Life Assessment" (82 trials), "Questionnaire Administration" (50 trials), "Paclitaxel" (45 trials) and "Carboplatin" (41 trials). Other intervention names were less common.

The vast majority of trials in "Medical Oncology and Hematology Associates-West Des Moines" are 270 trials for "All" genders, 68 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Oncology and Hematology Associates-West Des Moines". undefined are not yet recruiting, 75 are recruiting, 138 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 109 completed trials in Medical Oncology and Hematology Associates-West Des Moines, 4 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Oncology and Hematology Associates-West Des Moines, 13 "Phase 1" clinical trials were conducted, 172 "Phase 2" clinical trials and 170 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".